• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VASCUTEK LTD; GELWEAVE VALSALVA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VASCUTEK LTD; GELWEAVE VALSALVA Back to Search Results
Catalog Number 730030ADP
Device Problem Insufficient Information (3190)
Patient Problem Insufficient Information (4580)
Event Date 09/16/2020
Event Type  Injury  
Event Description
Clinical trial panther_32 patient number (b)(6), 40 year old male patient had a relevant medical condition of aortic valve regurgitation with possible device failure / deficiency of suspected graft leakage, and possibly related to the procedure but not related to pre-existing condition and surgical intervention.Patient had aortic bleeding.Graft leakage on mri to be confirmed by ett.Graft leakage seen in imaging did not lead to a clinical event with a need for reintervention.No action was taken.Note: no leakage was observed in ct scans at previous visit in (b)(6) 2019.Patient has not attended any further follow up visits.Site have been contacted to determine current status/ outcome of patient.
 
Manufacturer Narrative
Clinical code: 4580 insufficient information: additional information and pre/post op scans requested from site.Health effect: 2199 no health consequences or impact: graft remains implanted, graft leakage seen in imaging did not lead to a clinical event with a need for reintervention.Medical device problem: 3190 insufficient information: additional information and pre/post op scans requested from site.Type of investigation: 4114 device not returned: device remains implanted.3331 analysis of production record: all manufacturing and qc records reviewed, and device was built to speciation.4110 trend analysis: : a 5 year review of similar events for leakage? unknown leakage type? unknown location was performed which gave and occurrence rate of 0.001%.
 
Event Description
Clinical trial panther_32 patient number 100, 40 year old male patient had a relevant medical condition of aortic valve regurgitation with possible device failure / deficiency of suspected graft leakage, and possibly related to the procedure but not related to pre-existing condition and surgical intervention.Patient had aortic bleeding.Graft leakage on mri to be confirmed by ett.Graft leakage seen in imaging did not lead to a clinical event with a need for reintervention.No action was taken.Note: no leakage was observed in ct scans at previous visit in march 2019.Patient has not attended any further follow up visits.Site have been contacted to determine current status/ outcome of patient this report is being submitted as a final for mfg report fda 9612515-2023-00009 comp 5083.Additional information recieved from site on 09 aug 23 confirmed that this event was not device related.
 
Manufacturer Narrative
Clinical code: 4580 insufficient information: additional information and pre/post op scans requested from site.Health effect: 2199 no health consequences or impact: graft remains implanted, graft leakage seen in imaging did not lead to a clinical event with a need for reintervention.Medical device problem: 3190 insufficient information: additional information and pre/post op scans requested from site.Type of investigation : 4114 device not returned: device remains implanted.3331 analysis of production record: all manufacturing and qc records reviewed, and device was built to speciation.4110 trend analysis: a 5-year review of similar events for leakage >> unknown leakage.Type >> unknown location was performed which gave and occurrence rate of (b)(4).4111 communication/ interviews: emailed site for additional information on this event.Investigation finding's: 213 no device problem found: email from site confirmed this event was not device related.Investigation conclusion: 67 no problem detected: email from site confirmed this event was not device related.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Type of Device
GELWEAVE VALSALVA
Manufacturer (Section D)
VASCUTEK LTD
newmains avenue
inchinnan
glasgow, PA49R R
UK  PA49RR
Manufacturer (Section G)
VASCUTEK LTD
newmains avenue
inchinnan
glasgow, PA49R R
UK   PA49RR
Manufacturer Contact
jason whittle
newmains avenue
inchinnan
glasgow, PA49R-R
UK   PA49RR
MDR Report Key17478437
MDR Text Key320569482
Report Number9612515-2023-00009
Device Sequence Number1
Product Code DSY
UDI-Device Identifier05037881120133
UDI-Public05037881120133
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K013022
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study
Reporter Occupation Physician
Remedial Action Other
Type of Report Initial,Followup
Report Date 08/07/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/31/2021
Device Catalogue Number730030ADP
Device Lot Number17558775
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/13/2023
Initial Date FDA Received08/08/2023
Supplement Dates Manufacturer Received07/13/2023
Supplement Dates FDA Received08/09/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/16/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age40 YR
Patient SexMale
-
-